Committees2018-07-06T13:51:50+00:00

Committees

Committee members play a critical role in providing FDLI with subject-matter and editorial advisory expertise. Service on committees is limited to FDLI members. The nomination process for one-year committee service opens each fall.

  • Laura Brown (Staff Liaison), FDLI
  • Kellie Combs, Ropes & Gray LLP
  • Dale Cooke, PhillyCooke Consulting
  • Lisa Dwyer, King & Spalding LLP
  • Mark Gaydos, Sanofi
  • Kelly Goldberg, PhRMA
  • Wayne Pines, APCO Worldwide
  • Jennifer Romanski, Porzio Bromberg & Newman, P.C.
  • Lucy Rose, Lucy Rose & Associates, LLC
  • Paul Savidge, Spark Therapeutics
  • Ellen Schumacher, Bristol-Myers Squibb Company
  • Laura Brown (Staff Liaison), FDLI
  • Carla Cartwright (Co-Chair), Johnson & Johnson
  • Neil DiSpirito (Co-Chair), Ballard Spahr LLP
  • Stacey Gagosian, Truth Initiative
  • Martin Hahn, Hogan Lovells US LLP
  • Lori Hirsch, Bristol-Myers Squibb
  • John Manthei, Latham & Watkins LLP
  • Jeff Nelligan, FDA – ORA
  • Amy Norris, Clif Bar & Company
  • Jeannie Perron, Covington & Burling LLP
  • Cassie Scherer, Medtronic
  • William Schultz, Zuckerman Spaeder LLP
  • Julie Tierney, FDA – OBER
  • Michael Werner, Holland & Knight LLP
  • Paige Samson (Staff Liaison), FDLI
  • Deborah Autor, Mylan Pharmaceuticals, Inc.
  • John Garvey, Compliance Architects LLC
  • George Karavetsos, DLA Piper LLP
  • Mark Mansour, Foley Hoag LLP
  • Matthew Newcomer, Post & Schell, P.C.
  • Cynthia Schnedar, Greenleaf Health, Inc.
  • Howard Sklamberg, Akin Gump Strauss Hauer & Feld LLP
  • Kimberly Trautman, NSF International
  • Anne Walsh, Hyman Phelps & McNamara, PC
  • Jessica Zeller, FDA – ORA
  • Laurie J. Beyranevand, Vermont Law School
  • Marsha A. Echols, Howard Univserity
  • Victoria Girard, Georgetown University
  • Lewis Grossman, American University
  • Sam Halabi, University of Missouri Columbia School of Law
  • Ralph Hall, Leavitt Partners, LLC
  • Stuart Kim, Cardinal Health, Inc.
  • Erika F. Lietzan, University of Missouri Columbia School of Law
  • Dorthy Linvill-Neal, Novartis Pharmaceuticals Corporation
  • Jordan Paradise, Loyola University
  • Gael Tisack, Wichita State University
  • Hayley Carpenter (Staff Liaison), FDLI
  • Daniel Kracov (Chair), Arnold & Porter LLP
  • Steven H. Armstrong, EAS Consulting Group, LLC
  • Cathy Burgess, Alston & Bird LLP
  • Stuart Pape, Polsinelli PC
  • Hayden Galante (Staff Liaison), FDLI
  • Melissa Card-Abela, Michigan State University
  • Ariella Cohen, The Pew Charitable Trusts
  • Yolande Dufresne, Torys LLP
  • Jane Kalinina, Foley Hoag LLP
  • Kristen Klesh, Venable LLP
  • Chia-Feng Lu, Baker & McKenzie
  • Caitlyn Ozier, King & Spalding LLP
  • Sung Park, FDAImports.com, LLC / Benjamin L. England & Associates, LLC
  • Carrie A. Scrufari, New York Department of State
  • Jennifer Thomas, Hyman Phelps & McNamara PC
  • Jeffrey N. Gibbs (Chair), Hyman, Phelps & McNamara, PC *
  • Jennifer L. Bragg (Vice Chair), Skadden, Arps, Slate, Meagher & Flom LLP
  • Frederick R. Ball (Treasurer), Duane Morris LLP *
  • Joy J. Liu (Secretary and General Counsel), Vertex Pharmaceuticals, Inc. *
  • Amy Comstock Rick (President & CEO), FDLI *
  • Stacy L. Ehrlich, Kleinfeld, Kaplan & Becker, LLP
  • Margaret Foster Riley, University of Virginia Schools of Law and Medicine
  • Jeffrey K. Francer, Association for Accessible Medicines
  • Miriam Guggenheim, Covington & Burling, LLP
  • Freddy A. Jimenez, Celldex Therapeutics, Inc.
  • Elizabeth Jungman, The Pew Charitable Trusts
  • Sandra Cohen Kalter, Medtronic
  • Daniel Kracov, Arnold & Porter LLP
  • Scott M. Melville, Consumer Healthcare Products Association (CHPA)
  • Francis B. Palumbo, University of Maryland School of Pharmacy
  • Robert Rhoades, Validant

* denotes Board Member is also a member of the Executive Committee

  • Laura Brown (Staff Liaison), FDLI
  • Khara Minter (Staff Liaison), FDLI
  • Wade Ackerman, Covington & Burling LLP
  • Heather Howell, NSF International
  • Vinita Kailasanath, Arnold & Porter LLP
  • Emily Marden, Sidley Austin LLP
  • Kai Peters, Gordon & Rees LLP
  • Deborah Tolomeo, Genentech, Inc.
  • Frederick R. Ball (Chair), Duane Morris LLP
  • Scott M. Melville (Board Liaison), Consumer Healthcare Products Association (CHPA)
  • Hayley Carpenter (Staff Liaison), FDLI
  • Amy Norris, Clif Bar & Company
  • Peter Pitts, Center for Medicine in the Public Interest
  • Stuart TenHoor, Stuart TenHoor Legal Search
  • Laura Brown (Staff Liaison), FDLI
  • Rend Al-Mondhiry, Amin Talati & Upadhye, LLP
  • Steven H. Armstrong, EAS Consulting Group, LLC
  • Sandra Eskin, The Pew Charitable Trusts
  • August T. Horvath, Foley Hoag LLP
  • Alissa Jijon, U.S. Pharmacopeia
  • Meredith Olearchik, Campbell Soup Company
  • John Packman, The Coca-Cola Company
  • Stuart Pape, Polsinelli PC
  • Jason Sapsin, Faegre Baker Daniels LLP
  • Brooke Schumm, Daneker, McIntire, Schumm
  • Suzanne Trigg, Haynes and Boone LLP
  • Amanda Triner, FDA – CFSAN
  • Kurt D. Weaver, Womble Bond Dickinson LLP
  • Judy Rein (Staff Liaison), FDLI
  • Anthony J. Anscombe, Steptoe & Johnson LLP
  • Barbara A. Binzak Blumenfeld, Buchanan Ingersoll & Rooney PC
  • Marie Boyd, University of South Carolina
  • Catherine Clements, Eli Lilly and Company
  • Thomas Colonna, Johns Hopkins University
  • Brian A. Dahl, Dahl Compliance Consulting LLC
  • Jeffrey K. Francer, Association of Accessible Medicines
  • Robert C. Giddings, Hutchison PLLC
  • Abraham Gitterman, Arnold & Porter LLP
  • Kimberly J. Gold, Norton Rose Fulbright Canada LLP
  • Peter B. Hutt II, Akin Gump Strauss Hauer & Feld LPP
  • William Janssen, Charleston School of Law
  • John Johnson, FDAImports.com LLC, Benjamin L. England & Associates LLC
  • Alan C. Katz, toxCel, LLC
  • Sara Koblitz, Hyman Phelps & McNamara PC
  • Natasha Leskovsek, Cooley LLP
  • Priya Mannan, Novartis Pharmaceuticals Corporation
  • Alexandra Marzelli, FDA – OC
  • Alan Minsk, Arnall Golden Gregory LLP
  • Nicole Negowetti, Harvard Law School
  • James T. O’Reilly, University of Cincinatti
  • Joseph A. Page, Georgetown University
  • Sandra Retzky, FDA – CTP
  • Jessica Ringel, King & Spalding LLP
  • Sarah Roller, Kelley Drye & Warren LLP
  • Marc J. Scheineson, Alston & Bird LLP
  • Jodi Schipper, Federal Government
  • David C. Spangler, Consumer Healthcare Products Association (CHPA)
  • Christopher G. Van Gundy, Keller and Heckman LLP
  • Andrew Wasson, Haug Partners LLP
  • James W. Woodlee, Kleinfeld, Kaplan & Becker
  • Emily Wright, Pfizer, Inc.
  • Kimberly F. Yocum, Ideaish
  • Lowell Zeta, Hogan Lovells US LLP
  • Patricia Zettler, Georgia State University
  • Laura Brown (Staff Liaison), FDLI
  • Paul Gadiock, Arent Fox LLP
  • Robert Guzman, Thompson Hine LLP
  • Sonali P. Gunawardhana, Shook, Hardy & Bacon
  • Chad Landmon, Axinn, Veltrop & Harkrider LLP
  • Mark Levy, Eckert Seamans Cherin & Mellott, LLC
  • John McShane, Validant
  • Vernessa T. Pollard, McDermott Will & Emery
  • Jeffrey K. Shapiro, Hyman, Phelps & McNamara, PC
  • Lance Shea, BakerHostetler
  • Deborah Shelton, McCarter & English LLP
  • Sarah H. Stec, Squire Patton Boggs LLP
  • Rachel Turow, TEVA Pharmaceutical USA, Inc.
  • Paige Samson (Staff Liaison), FDLI
  • Amy Arthur, Junior Associate, Pinney Associates, Inc.
  • Shelby Buettner, Associate, McDermott Will & Emery
  • Ariella Cohen, Associate, Health Care Products, The Pew Charitable Trusts
  • Delia Deschaine, Senior Associate, Hogan Lovells US LLP
  • Steven Gonzalez, Associate, Polsinelli PC
  • Rachael Hunt, Attorney, Hyman, Phelps & McNamara, PC
  • Elizabeth Mulkey, Associate, Arnall Golden Gregory LLP
  • Megan Robertson, Associate, Epstein Becker & Green, PC
  • Shane Schwartz, Corporate Attorney, Otsuka America Pharmaceuticals, Inc.
  • Steven Tjoe, Associate, Goodwin Procter LLP
  • Judy Rein (Staff Liaison), FDLI
  • Ricardo Carvajal, Hyman, Phelps & McNamara PC
  • Joanne Hawana, Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. 
  • Marian J. Lee, Gibson, Dunn & Crutcher LLP
  • Laurie Lenkel, FDA – OC
  • Geoffrey Levitt, Pfizer, Inc.
  • Lynn Tyler, Barnes & Thornburg LLP
  • Judy Rein (Staff Liaison), FDLI
  • Carolyn Alenci, Duane Morris LLP
  • Jacqueline Berman, Morgan, Lewis & Brockius LLP
  • Jacqueline Chan, Kleinfeld, Kaplan & Becker
  • Sarah diFrancesca, Cooley LLP
  • Bridget C.E. Dooling, Office of Management & Budget
  • Maya Florence, Skadden, Arps, Slate, Meagher & Flom LLP
  • Shelly Garg, Sandler, Travis & Rosenberg, P.A.
  • Colleen M. Heisey, Jones Day
  • Gail Javitt, Epstein Becker Green, PC
  • James R. Johnson, Hogan Lovells US LLP
  • Susan Lee, Hogan Lovells US LLP
  • Kari K. Loeser, Jazz Pharmaceuticals, Inc.
  • Kevin Madagan, Reed Smith LLP
  • Timothy Moore, BD
  • Jessica O’Connell, Covington & Burling LLP
  • Nneka C. Onwudiwe, FDA – CDER (serving in a personal capacity)
  • Sudhanshu Patwardhan, British American Tobacco
  • Evangelia Pelonis, Keller and Heckman LLP
  • Kai Peters, Gordon & Rees LP
  • Barry Schaevitz, Fox Rothschild LLP
  • Laura Sim, Amgen Inc.
  • Genevieve M. Spires, Buchanan Ingersoll & Rooney PC
  • Smitha G. Stansbury, King & Spalding LLP
  • Sara Zborovski, Norton Rose Fulbright Canada LLP
  • Paige Samson (Staff Liaison), FDLI
  • David Abrams, New York University
  • Scott Ballin, Independent Consultant
  • Donald Becker, Turning Point Brands, Inc.
  • Dean R Cirotta, EAS Consulting Group, LLC
  • Azim Chowdhury, Keller and Heckman LLP
  • Marc Firestone, Philip Morris International
  • Carole Folmar, ITG Brands
  • Robyn Gougelet, Senior Associate, Pinney Associates, Inc.
  • Bryan M. Haynes, Troutman Sanders LLP
  • Dennis Henigan, Campaign for Tobacco-Free Kids
  • Kathleen Hoke, University of Maryland Law School
  • Eshael Johnson, FDA – CTP
  • Jose Murillo, Altria Client Services LLC
  • Ray Niaura, New York University
  • Elizabeth Oestreich, Greenleaf Health, Inc.
  • Valerie Solomon, RAI Services Company
  • Donna Vallone, Truth Initiative